The Signal Journal
Back

Tag

pharma-litigation

Judge Rejects Bayer Bid to Block J&J Erleada Ads

Judge Dale Ho in Manhattan denied Bayer's request to block Johnson & Johnson's advertising claiming Erleada cuts prostate cancer mortality risk by 51%, finding Bayer unlikely to prevail on its false advertising claims. The ruling leaves J&J's marketing campaign intact while the underlying lawsuit continues. Nubeqa and

← Back

Tag

pharma-litigation

— End of feed —